ACXIF yields 2.30% · JNJ yields 2.13%● Live data
📍 ACXIF pulled ahead of the other in Year 1
Combined, ACXIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACXIF + JNJ for your $10,000?
Acciona, S.A., together with its subsidiaries, engages in the energy, infrastructure, and other businesses in Spain and internationally. The company develops, constructs, operates, and maintains wind, solar photovoltaic, solar thermal, hydro, and biomass plants. It also engages in designing, construction, maintenance, and management of infrastructure projects, including bridges, highways, motorways, roads, tunnels, railway, and metros and trams, as well as ports and water channels, airports, freight forwarding, data centers, substations, and transmission lines. In addition, the company offers event planning and management services, as well as designs, constructs, and operates drinking water treatment plants, reverse osmosis desalination plants, wastewater treatment plants, and tertiary treatment plants for water reuse; and constructs, operates, and manages healthcare, universities and campuses, ecosystems restoration, museums and exhibitions, and event planning and management; Further, it provides hotels and holiday resorts, offices, and industrial properties; financial solutions; facility management and airport handling; and museum interior design. It also engages in the fund management, stock broking, real estate, motorbike sharing, and other businesses. Acciona, S.A. was founded in 1916 and is headquartered in Alcobendas, Spain.
Full ACXIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.